315 related articles for article (PubMed ID: 30798468)
1. Management of Adrenocortical Carcinoma.
Jasim S; Habra MA
Curr Oncol Rep; 2019 Feb; 21(3):20. PubMed ID: 30798468
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
Libé R; Huillard O
Cancer Treat Res Commun; 2023; 37():100759. PubMed ID: 37690343
[TBL] [Abstract][Full Text] [Related]
3. Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.
Arakawa Y; Jo U; Kumar S; Sun NY; Elloumi F; Thomas A; Roper N; Varghese DG; Takebe N; Zhang X; Ceribelli M; Holland DO; Beck E; Itkin Z; McKnight C; Wilson KM; Travers J; Klumpp-Thomas C; Thomas CJ; Hoang CD; Hernandez JM; Del Rivero J; Pommier Y
Cancer Res Commun; 2024 Mar; 4(3):834-848. PubMed ID: 38451783
[TBL] [Abstract][Full Text] [Related]
4. Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma.
Pak C; Yoon S; Lee JL; Yun T; Park I
Curr Oncol Rep; 2024 Apr; 26(4):307-317. PubMed ID: 38381366
[TBL] [Abstract][Full Text] [Related]
5. Update on in-vivo preclinical research models in adrenocortical carcinoma.
Kar A; Wierman ME; Kiseljak-Vassiliades K
Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):170-176. PubMed ID: 32304391
[TBL] [Abstract][Full Text] [Related]
6. Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma.
Weng Y; Wang L; Wang XY; Fan XX; Yan L; Li ZH; Zhang SL
Front Endocrinol (Lausanne); 2023; 14():1115893. PubMed ID: 37745701
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients.
Kasperlik-Załuska AA; Migdalska BM; Zgliczyński S; Makowska AM
Cancer; 1995 May; 75(10):2587-91. PubMed ID: 7736405
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma.
Tai Y; Shang J
Front Endocrinol (Lausanne); 2023; 14():1260701. PubMed ID: 38269250
[TBL] [Abstract][Full Text] [Related]
9. Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies.
Lerario AM; Mohan DR; Hammer GD
Endocr Rev; 2022 Nov; 43(6):1051-1073. PubMed ID: 35551369
[TBL] [Abstract][Full Text] [Related]
10. Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy.
Lin Y; Yang S; Yang W; Cheng H; Chang X; Zhu Z; Feng J; Han J; Ren Q; Chang S; Liu S; Yu T; Hou B; Li P; Meng D; Zhang X; Qin H; Wang H
Eur J Med Res; 2023 Oct; 28(1):411. PubMed ID: 37814272
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma.
Murtha TD; Brown TC; Rubinstein JC; Haglund F; Juhlin CC; Larsson C; Korah R; Carling T
Surgery; 2017 Jun; 161(6):1667-1674. PubMed ID: 28073588
[TBL] [Abstract][Full Text] [Related]
12. Targeted genomic analysis of 364 adrenocortical carcinomas.
Pozdeyev N; Fishbein L; Gay LM; Sokol ES; Hartmaier R; Ross JS; Darabi S; Demeure MJ; Kar A; Foust LJ; Koc K; Bowles DW; Leong S; Wierman ME; Kiseljak-Vassiliades K
Endocr Relat Cancer; 2021 Aug; 28(10):671-681. PubMed ID: 34410225
[TBL] [Abstract][Full Text] [Related]
13. Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE.
Hescot S; Debien V; Hadoux J; Drui D; Haissaguerre M; de la Fouchardiere C; Vezzosi D; Do Cao C; Libé R; Le Tourneau C; Baudin E; Massard C; du Rusquec P;
Eur J Cancer; 2023 Aug; 189():112917. PubMed ID: 37277263
[TBL] [Abstract][Full Text] [Related]
14. Novel targeted therapies in adrenocortical carcinoma.
Konda B; Kirschner LS
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):233-41. PubMed ID: 27119750
[TBL] [Abstract][Full Text] [Related]
15. Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane.
Cantini G; Niccolai E; Canu L; Di Gloria L; Baldi S; Propato AP; Fei L; Nannini G; Puglisi S; Nesi G; Ramazzotti M; Amedei A; Luconi M
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37695690
[TBL] [Abstract][Full Text] [Related]
16. Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis.
Turla A; Laganà M; Cremaschi V; Zamparini M; De Maria L; Consoli F; Abate A; Tamburello M; Alberti A; Sigala S; Grisanti S; Fontanella MM; Cosentini D; Berruti A
J Endocrinol Invest; 2024 Jan; 47(1):223-234. PubMed ID: 37354248
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry.
Balderrama-Brondani V; Griffin AM; Owen TJ; Merriman KW; Chahla BB; Varghese J; Jimenez C; Waguespack SG; Graham PH; Perrier ND; Fisher SB; Karam JA; Shah AY; Campbell M; Hassan MM; Habra MA
Endocr Pract; 2024 Jan; 30(1):25-30. PubMed ID: 37858722
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical Carcinoma in Childhood: A Systematic Review.
Riedmeier M; Decarolis B; Haubitz I; Müller S; Uttinger K; Börner K; Reibetanz J; Wiegering A; Härtel C; Schlegel PG; Fassnacht M; Wiegering V
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771430
[TBL] [Abstract][Full Text] [Related]
19. The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.
Mizdrak M; Tičinović Kurir T; Božić J
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33578890
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
